Morgan Stanley Upgrades Cencora, Calls Drug Distributors' Industry a 'Golden Era'

jueves, 29 de enero de 2026, 12:30 pm ET1 min de lectura
CAH--
COR--
MCK--

Morgan Stanley has upgraded Cencora and raised price targets for its rivals, McKesson and Cardinal Health, citing a "golden era" for drug distributors. The analyst, Erin Wright, believes that the industry deserves a premium valuation due to favorable market conditions. Cencora was specifically upgraded, with Wright highlighting the company's strong performance and growth potential.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios